ARTICLE | Distillery Therapeutics
Cancer
April 10, 2018 10:53 PM UTC
Mouse studies suggest inhibiting LGALS1 could help treat pancreatic ductal adenocarcinoma (PDAC). In a human KRAS (K-Ras)-expressing mouse model of PDAC, systemic LGALS1 knockout increased survival co...
BCIQ Target Profiles